Envenomation by Loxosceles spider is characterized by the development of dermonecrosis. In previous studies, we have demonstrated that increased expression/secretion of matrix metalloproteinases 2 and 9, induced by Loxosceles intermedia venom Class 2 SMases D (the main toxin in the spider venom), contribute to the development of cutaneous loxoscelism. In the present study we show that the more potent venom containing the Class 1 SMase D from Loxosceles laeta, in addition to increasing the expression/secretion of MMP2 and MMP9, also stimulates the expression of MMP7 (Matrilysin-1), which was associated with keratinocyte cell death. Tetracycline, a matrix metalloproteinase inhibitor, prevented cell death and reduced MMPs expression. Considering that L. laeta venom is more potent at inducing dermonecrosis than L. intermedia venom, our results suggest that MMP7 may play an important role in the severity of dermonecrosis induced by L. laeta spider venom SMase D. In addition, the inhibition of MMPs by e.g. tetracyclines may be considered for the treatment of the cutaneous loxoscelism.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831769 | PMC |
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0153090 | PLOS |
Heliyon
July 2024
Laboratorio de Estructura Biomolecular, Centro de Investigación en Alimentación y Desarrollo, A. C., Hermosillo, Sonora, Mexico.
spp. spiders can cause serious public health issues. Chemical control is commonly used, leading to health and environmental problems.
View Article and Find Full Text PDFInt J Biol Macromol
August 2023
Universidade Federal do Paraná, Departamento de Patologia Básica, Laboratório de Imunoquímica, Curitiba, PR, Brazil.
In the Americas and specially in Brazil, the Loxosceles intermedia, Loxosceles gaucho and Loxosceles laeta are the three most medically relevant brown spider species, and whose bites can lead to the condition known as loxoscelism. Here, we report the development of a tool capable of identifying a common epitope amongst Loxosceles sp. venom's toxins.
View Article and Find Full Text PDFCASE (Phila)
December 2022
Nuclear Cardiology Department, National Institute of Cardiology Ignacio Chavez, Tlalpan, Mexico City, Mexico.
• Loxoscelism can present with ST-segment elevation myocardial infarction pattern on electrocardiogram. • The differential of this presentation includes coronary vasospasm and perimyocarditis. • In children, Kounis syndrome must be distinguished from Kawasaki disease.
View Article and Find Full Text PDFComp Biochem Physiol Part D Genomics Proteomics
September 2022
Ezequiel Dias Foundation, Brazil. Electronic address:
Accidents involving spiders from the genus Loxosceles cause medical emergencies in several countries of South America. The species Loxosceles laeta is ubiquitously present in Peru and is responsible for severe accidents in this country. To further characterize L.
View Article and Find Full Text PDFToxicon
August 2022
Laboratorio de Toxinología, Centro Nacional de Productos Biológicos (CNPB), Instituto Nacional de Salud, Lima, Peru; Departamento de Bioquímica e Imunologia, ICB, Universidade Federal de Minas Gerais, Av. Antônio Carlos 6627, CEP, 31270-901, Belo Horizonte, Minas Gerais, Brazil. Electronic address:
Loxoscelism is a serious public health problem in Peru, with approximately 2500 accidents reported per year. To envision alternatives to cope with this health problem, the neutralizing humoral immune response against the lethal effects of Peruvian spider Loxosceles laeta venom was evaluated in a mouse model by immunization with a non-toxic multiepitopic protein (rMEPLox). This immunogen contains epitopes from an astacin-like metalloprotease, a hyaluronidase and a sphingomyelinase-D from Loxosceles intermedia and from SMase-I from L.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!